Drug Enforcement D-0189-2025

CGMP Deviations; Presence of N-nitroso-duloxetine impurity above recommended interim limit.

Status

Ongoing

Classification

Class II

Report Date

January 15, 2025

Termination Date

—

Product Information

Product description
Duloxetine Delayed-Release Capsules USP 20 mg, 60 count bottles, Rx only, Distributed by: Rising Pharm Holdings, Inc., East Brunswick, NJ NDC 57237-017-60
Product quantity
73,680 bottles
Reason for recall
CGMP Deviations; Presence of N-nitroso-duloxetine impurity above recommended interim limit.
Recall initiation reason
—
Initial firm notification
Letter
Distribution pattern
Nationwide

Location & Firm

Recalling firm
Rising Pharma Holding, Inc.
Address
2 Tower Center Blvd Ste 1401

United States
Voluntary / Mandated
Voluntary: Firm initiated
Status date
—

Codes & Dates

Recall number
D-0189-2025
Event ID
96074
Recall initiation date
December 30, 2024
Center classification date
January 8, 2025
Code info
Lot # DT2023003A, DT2023007A, DT2023008A, exp. date Jan-25
More code info
—